Zimmer Biomet
982 hedge funds and large institutions have $27.2B invested in Zimmer Biomet in 2021 Q3 according to their latest regulatory filings, with 84 funds opening new positions, 328 increasing their positions, 331 reducing their positions, and 104 closing their positions.
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
0.65% less ownership
Funds ownership: 92.54% → 91.89% (-0.65%)
1% less repeat investments, than reductions
Existing positions increased: 328 | Existing positions reduced: 331
4% less call options, than puts
Call options by funds: $105M | Put options by funds: $109M
4% less funds holding
Funds holding: 1,018 → 982 (-36)
9% less capital invested
Capital invested by funds: $30B → $27.2B (-$2.8B)
19% less first-time investments, than exits
New positions opened: 84 | Existing positions closed: 104
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$364M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$260M |
| 3 |
LP
Longview Partners
St Peter Port,
Guernsey
|
+$193M |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$171M |
| 5 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$110M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital Research Global Investors
Los Angeles,
California
|
-$636M |
| 2 |
N
Nuveen
Charlotte,
North Carolina
|
-$190M |
| 3 |
Two Sigma Advisers
New York
|
-$177M |
| 4 |
Two Sigma Investments
New York
|
-$154M |
| 5 |
Northern Trust
Chicago,
Illinois
|
-$118M |
ZBH Hedge Fund Activity: Q3 2021 in Review
982 of the 5,712 institutional investors tracked by Wall St. Rank reported a position in Zimmer Biomet (ZBH) for Q3 2021, worth a combined $27.2B — down 9.3% from $30B a quarter earlier.
Sellers outnumbered buyers: 104 funds closed out of ZBH and 84 opened new positions — a net loss of 20 holders — while 331 trimmed existing stakes and 328 added.
The largest buyer was JP Morgan Chase, adding an estimated $364M. The largest seller was Capital Research Global Investors, cutting an estimated $636M.
- 982 institutional investors held Zimmer Biomet (ZBH) as of Q3 2021, down from 1,018 in Q2 2021.
- Funds reported $27.2B of Zimmer Biomet stock for Q3 2021, down 9.3% quarter-over-quarter.
- 84 funds opened new Zimmer Biomet positions in Q3 2021 and 104 closed out, a net change of -20 holders.
- The largest Zimmer Biomet buyer in Q3 2021 was JP Morgan Chase, an estimated $364M added.
- The largest Zimmer Biomet seller in Q3 2021 was Capital Research Global Investors, an estimated $636M sold.
Based on aggregated 13F filings for Q3 2021.